In 2011, the post-Soviet countries started to build a single customs zone. As a result, the transport control was placed on the external borders of the member countries, and the domestic transportation of products became untraceable. In 2017, Russia imported 8.4 bln RUB worth of pharmaceutical drugs manufactured in the EEU countries (wholesale prices), which is in monetary terms 9.1% higher than that of 2016. In physical terms, Russia imported nearly 212 mln units of drugs, which is 3.5% lower than that of 2016.

In January 2018, Russia imported 4.7 bln RUB worth of APIs (free circulation prices, VAT included), which is in monetary terms 7% lower than that of January 2017. In physical terms, Russia imported nearly 860 tons of APIs, which is 18% higher than that of January 2017.

In January 2018, Russia imported 1.9 bln RUB worth of feed supplements (free circulation prices), which is in monetary terms 13% lower than that of January 2017, 1.3 bln RUB worth of veterinary drugs, which is 3% higher than that of January 2017, and 200 mln RUB worth of veterinary APIs, which is as much as 62% higher than that of January 2017.

In January 2018, Russia imported 30.6 bln RUB worth of ready-made drugs (free circulation prices), which is in monetary terms 1.5% higher than that of January 2017, and 6.5 bln RUB worth of in-bulk drugs, which is 4.4% lower than that of January 2017.

Between January and February 2018, Russian manufacturers dispatched 46.9 bln RUB worth of pharmaceutical drugs (dispatch prices, VAT included), which is in monetary terms 1.3% lower than that of the same period of 2017. In physical terms, Russia produced nearly 670 units of drugs, which is 4.9% lower than that of the same period of 2017. The production of over-the-counter drugs has fallen by 9.5%, while the Rx category has a 3.8% growth.